MedPath

ADSOL RED CELL PRESERVATION

Code REF PQ312US NDC No. 0942-6528-01 20x Rx only Fresenius Kabi

Approved
Approval ID

7c6ec336-7211-41cd-b822-08fd25e7fae2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 22, 2022

Manufacturers
FDA

Fenwal, Inc.

DUNS: 794519020

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

anticoagulant citrate phosphate dextrose (cpd) and adsol preservation

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0942-6528
Application NumberBN811104
Product Classification
M
Marketing Category
C73594
G
Generic Name
anticoagulant citrate phosphate dextrose (cpd) and adsol preservation
Product Specifications
Effective DateJune 16, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ADSOL RED CELL PRESERVATION - FDA Drug Approval Details